Facial Skincare Adverse Event Atlas and Safety Signals From openFDA Cosmetic Reports: A Disproportionality Analysis. [PDF]
J Cosmet DermatolABSTRACT Objective To construct a facial‐skincare adverse event atlas and detect category‐level safety signals using the US FDA openFDA Cosmetic Adverse Events database. Methods We analyzed publicly available openFDA cosmetic adverse event reports (downloaded 2025‐12‐15; meta.last_updated 2025‐12‐10).
Sun Z, Xiang H, Fan Z.
europepmc +2 more sources
Value co-creation in healthcare: evidence from innovative therapeutic alternatives for hereditary angioedema [PDF]
, 2018 Background Our research focuses on the co-creation of value in healthcare with reference to a case of hereditary angioedema with C1 inhibitor deficiency (C1-INH-HAE). Our work is mainly based on the concept of value co-creation in healthcare.
Barbarino, Alessandro +3 more
core +1 more source
Allergy, EarlyView.A prospective, systematic and cross‐sectional population study was performed involving 1000 adult subjects from five centers representing different climatic areas of Türkiye (Turkey). Molecular IgE profiling demonstrated substantial interregional variation and identified a hypoallergenic region in the easternmost area with a continental climate.
Alp Kazancioglu +22 more
wiley +1 more source
Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke [PDF]
, 2018 Background: Orolingual angioedema can occur during thrombolysis with alteplase in stroke patients. However, data about its frequency, severity and the significance of concurrent use of angiotensin-converting-enzyme inhibitors (ACEi) are sparse. Objective:
Buitrago-Téllez, C. +6 more
core
Initial Results from a Phase 1 Single Ascending Dose Clinical Trial of STAR-0215, an Investigational Long-Acting Monoclonal Antibody Plasma Kallikrein Inhibitor for Hereditary Angioedema (HAE), in Healthy Subjects Followed for at Least 3 Months [PDF]
, 2023 Christopher Morabito +8 more
openalex +1 more source
Allergy, EarlyView.Ligelizumab re‐treatment in CSU patients showed sustained efficacy and tolerability. Over 50% achieved symptom control (UAS7 ≤ 6) by Week 12; benefits maintained through Week 52. No new safety signals observed; aligns with prior PEARL trial outcomes. CSU, chronic spontaneous urticaria; mg, milligram; q4w, every 4 weeks; UAS, urticaria activity score ...
Ana M. Gimenez‐Arnau +22 more
wiley +1 more source
design of the HELP study extension [PDF]
, 2017 Background Hereditary angioedema (HAE) is characterized by recurrent attacks of subcutaneous or submucosal edema. Attacks are unpredictable, debilitating, and have a significant impact on quality of life.
Banerji, Aleena +11 more
core +1 more source
Recent Advances in Drug-Induced Angioedema
Allergology International, 2012 Angioedema is the end result of deep dermal, subcutaneous and/or mucosal swelling, and is potentially a life- threatening condition in cases where the pharynx or larynx is involved. Drug-induced angioedema has been reported to occur in response to a wide
Naoko Inomata
doaj +1 more source
Andrógenos en el tratamiento de mantenimiento a largo plazo del angioedema hereditario. ¿Es el momento de pensar en otras opciones? [PDF]
, 2016 El angioedema hereditario (AEH) es una enfermedad transmitida con un patrón autosómico dominante, caracterizada por la presencia de angioedema recurrente y ocasionada por un defecto de la enzima conocida como inhibidor de C1.
Frías Iniesta, Jesús
core +1 more source
Mimotope mapping as a complementary strategy to define allergen IgE-epitopes: peach Pru p 3 allergen as a model. [PDF]
, 2008 Lipid transfer proteins (LTPs) are the major allergens of Rosaceae fruits in the Mediterranean area. Pru p 3, the LTP and major allergen of peach, is a suitable model for studying food allergy and amino acid sequences related with its IgE-binding ...
Compes, Esther +7 more
core +2 more sources